AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Eli Lilly's Stock Dynamics and the Pharmaceutical Landscape
This chapter explores the recent decline in Eli Lilly's stock, driven by a disappointing outlook for its GLP-1 drugs. It examines investor hesitation, competitive pressures in the pharmaceutical market, and the implications of changing market dynamics.